BioSpace News Archive

Press Releases

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) - March 20, 2026

March 23, 2026
·
1 min read
Press Releases

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 20, 2026

March 23, 2026
·
1 min read
Press Releases

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

March 23, 2026
·
19 min read
Press Releases

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - March 20, 2026

March 23, 2026
·
3 min read
Press Releases

Curi Bio and Battelle Announce Strategic Partnership to Accelerate the Adoption of New Approach Methods in Neuromuscular Pharmacology

March 23, 2026
·
3 min read
Press Releases

Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment

March 23, 2026
·
2 min read
Press Releases

Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)

March 23, 2026
·
6 min read
Press Releases

IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy

March 23, 2026
·
3 min read
Press Releases

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026

March 23, 2026
·
7 min read
Press Releases

IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

March 23, 2026
·
3 min read